Literature DB >> 1553963

Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.

C Sanders, E A Perez, H J Lawrence.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1553963     DOI： 10.1002/ajh.2830390418

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Lysis pneumonopathy associated with the use of fludarabine phosphate.

Authors:  J J Crowley; L Knight; N Charan
Journal:  West J Med       Date:  1994-12

Review 2.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.

Authors:  A Leenders; P Sonneveld; S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 4.  Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.

Authors:  S R Ross; D McTavish; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.